Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Guardforce AI Implements Smart Solutions and AI Applications in Thailand
-
UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in
-
Vertex Report: U.S. Sees Continued Acceleration in Sales Tax Rates and Rules Changes
-
Deliverect Partners with FreedomPay to Transform Payment Operations for Restaurant Chains
-
Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’
-
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
-
Changes in Nokia Corporation's own shares
-
JDE Peet’s share buyback periodic update July 28, 2025
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ProQR Announces Upcoming Presentation at RNA Editing Summit
-
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
-
Form 8.3 - [Insert name of offeree or offeror]
-
Interfor Renews and Extends Its Credit Facilities with Enhanced Financial Flexibility
-
Sotera Health Announces Second-Quarter 2025 Earnings Release Date
-
HealthLynked Launches New Enterprise Healthcare Solutions Website and Upgraded Provider Directory to Expand Strategic Value Across the Healthcare Market
-
Health Insurance and Policy Expert Elizabeth Goodman Joins FTI Consulting’s Healthcare and Life Sciences Practice
-
Midland Announces Closing of $6.1 Million Private Placement with Strategic Investment from Centerra Gold
-
Almaden Provides Update on Arbitration Procedure with Mexico
-
Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis
-
3 E Network Technology Group Limited Announces Use from First Tranche Private Offering Proceeds to Purchase Bitcoin and Advance Web 3.0 Strategy
-
DallasNews Corporation Rejects Unsolicited Non-Binding Proposal from Affiliate of Alden Global Capital
-
Millennium Group International Holdings Expands Global Footprint with Official Launch of Vietnam Manufacturing Facility
-
Digi Power X Subsidiary, US Data Centers Inc., Files Provisional Patent for ARMS 200 Modular AI Data Center Platform
-
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
-
Purpose Investments Inc. Announces Final July 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy
-
Exodus Movement, Inc. to Announce Second Quarter 2025 Results on August 11, 2025
-
Bio Usawa Biotechnology (Bio Usawa) Partners with DEK Vaccines Ltd (DEK) to Expand Access to Life-Saving Biopharmaceuticals Across Ghana and West Africa
-
Firefly Aerospace Announces Launch of Initial Public Offering
-
Costamare Inc. Sets the Date for Its Second Quarter 2025 Results Release, Conference Call and Webcast
-
ASHTON WOODS USA L.L.C. ANNOUNCES EXPIRATION AND RESULTS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING 6.625% SENIOR NOTES DUE 2028
-
Kraig Biocraft Laboratories Signs Landmark Collaborative Agreement with Government Agency in Southeast Asia to Advance Spider Silk Production
-
Transactions in connection with share buyback programme
-
Vietnam Blockchain Association renamed to “Vietnam Blockchain and Digital Assets Association”
-
Aktsiaselts Infortar Investor Webinar introducing the results of the Q2 2025
-
AMG and Montefiore Investment Announce Partnership
-
Opendoor to Adjourn Special Meeting of Stockholders to August 27, 2025
-
Immutable Holdings Announces Strategic Update on HBAR Treasury Strategy Also Management Change
-
Foodservice outlook improves slightly in Q2, but remains fragile amid trade tensions and cost volatility
-
Guardian Capital Announces Fund Name Change
-
Cielo Announces Closing of First Tranche of Unit Offering and Closing of Securities for Debt Transactions
-
Sable Announces Termination of Don Julio Project Earn-in Agreement with South32 and Highlights Exploration Upside in Four Identified Porphyry Targets
-
Dermatologists Top the List as Key Influencers in Patients’ Cosmetic Procedure Decisions
-
Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival (“PFS”) Primary Endpoints from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial
-
Next Hydrogen Successfully Energizes Ontario’s largest Onsite Clean Hydrogen Fueling Station at a Distribution Centre
-
FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency
-
Playboy to Report Second Quarter 2025 Financial Results on August 12, 2025
-
CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod’s Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated
-
BTCS Inc. Reaches Significant Milestone, Surpassing $275 Million of Ethereum and Assets on Balance Sheet
-
Breakthrough Study from UCLA Demonstrate Can-Fite’s Piclidenoson as a Treatment for Vascular Dementia
